Tirzepatide

Premium Quality Research Peptide

A$100.00

Tirzepatide (TR 50) 10mg from WA Peptides is a premium laboratory-grade research peptide developed exclusively for scientific and experimental applications. Manufactured under stringent quality control standards, this product is formulated to provide exceptional purity, consistency, and reliability for qualified researchers conducting laboratory and preclinical studies.

Each vial contains 10mg of Tirzepatide (TR 50) and is professionally sealed to help maintain product stability and integrity throughout storage and handling, ensuring dependable performance in controlled research environments.

What Is Tirzepatide?

Tirzepatide is a long-acting synthetic peptide engineered to activate both:

  • Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor

  • Glucagon-Like Peptide-1 (GLP-1) receptor

Unlike compounds targeting only one incretin pathway, Tirzepatide combines dual receptor activity, making it an important molecule for studying metabolic regulation and endocrine signaling.


Mechanism of Action

Tirzepatide functions by activating both the GIP and GLP-1 receptors.

In research models, activation of these receptors has been associated with:

  • Enhanced glucose-dependent insulin secretion

  • Reduced glucagon release during elevated glucose conditions

  • Delayed gastric emptying

  • Regulation of appetite-related signaling

  • Reduced food intake

  • Improved insulin sensitivity

  • Modulation of energy expenditure

Its dual-receptor activity distinguishes it from selective GLP-1 receptor agonists and provides researchers with opportunities to study synergistic incretin signaling.


Summary of Publicly Available Research

Published research has investigated Tirzepatide in several metabolic and endocrine settings.

Studies have explored:

  • Blood glucose regulation

  • Weight reduction mechanisms

  • Insulin sensitivity

  • Beta-cell function

  • Cardiometabolic biomarkers

  • Lipid metabolism

  • Liver fat reduction

  • Appetite regulation

  • Long-term metabolic adaptation

Clinical investigations have demonstrated substantial improvements in glycemic control and body weight compared with several established incretin therapies, contributing to significant scientific interest in dual incretin receptor agonism.

Research remains ongoing to further characterize long-term physiological effects and broader metabolic applications.


Key Research Areas

Researchers commonly investigate Tirzepatide in studies involving:

  • Metabolic disease models

  • Obesity research

  • Type 2 diabetes mechanisms

  • Insulin resistance

  • Energy balance

  • Appetite regulation

  • Endocrinology

  • Pancreatic beta-cell biology

  • Cardiometabolic health

  • Liver metabolism

  • Lipid regulation

  • Incretin biology


Chemical Information

Property

Information

Compound

Tirzepatide

Common Name

Tirzepatide

Abbreviation

TR 50

Molecular Type

Synthetic peptide

Peptide Class

Dual GIP/GLP-1 receptor agonist

Appearance

Lyophilized white to off-white powder

Purity

≥98% (batch dependent)

Solubility

Soluble in bacteriostatic water or sterile laboratory-grade water for research applications

Storage Form

Lyophilized powder


Storage Recommendations

For maximum stability:

  • Store lyophilized product between 2°C–8°C

  • Protect from heat, moisture, and direct light

  • Keep vial tightly sealed until use

  • After reconstitution, refrigerate according to laboratory protocols

  • Avoid repeated freeze-thaw cycles

  • Use sterile laboratory handling procedures during preparation

Proper storage helps preserve peptide integrity for research applications.


Certificate of Analysis (COA)

Each production batch undergoes quality control testing before release.

Typical COA information includes:

  • Batch/Lot Number

  • Product Identification

  • Purity Analysis (HPLC)

  • Molecular Weight Verification (Mass Spectrometry)

  • Appearance Inspection

  • Identity Confirmation

  • Manufacturing Date

  • Expiration or Retest Date

A batch-specific Certificate of Analysis is available upon request where applicable.


Customer Reviews

⭐⭐⭐⭐⭐ Excellent Quality
"Consistent product quality and excellent packaging. Arrived well protected for laboratory use."

⭐⭐⭐⭐⭐ Reliable Research Material
"Clean appearance and documentation provided as expected. Will order again."

⭐⭐⭐⭐⭐ Fast Shipping
"Professional packaging and prompt delivery. Product matched specifications."

⭐⭐⭐⭐⭐ Great Experience
"Very satisfied with the overall purchasing process and product consistency."


Frequently Asked Questions

Is this product intended for human use?

No. This product is supplied strictly for laboratory research purposes only.

What form does the product arrive in?

It is supplied as a lyophilized (freeze-dried) peptide powder.

How should it be stored?

Store refrigerated at 2°C–8°C in its original sealed container. Protect from moisture and light.

Is a Certificate of Analysis available?

Yes. Batch-specific COAs are available for qualifying products or upon request.

What makes Tirzepatide unique?

Tirzepatide is notable for its dual activation of both GIP and GLP-1 receptors, allowing researchers to investigate combined incretin signaling pathways.


Related Products

Researchers interested in Tirzepatide may also explore:

  • Retatrutide

  • Semaglutide

  • Cagrilintide

  • Survodutide

  • Mazdutide

  • Liraglutide

  • Dulaglutide

  • Exenatide

  • Tesamorelin

  • AOD-9604


Research Disclaimer: This product is intended exclusively for laboratory research conducted by qualified professionals. It is not approved for human consumption, therapeutic use, or veterinary use. Researchers are responsible for complying with all applicable laws, regulations, and institutional guidelines regarding the handling and use of research chemicals.